Diako Ev. Diakonie-Krankenhaus gemeinnützige GmbH
1 clinical trials · Sponsor
◉ Watch Diako Ev. Diakonie-Krankenhaus gemeinnützige GmbH
| Record | Firm | Date |
|---|---|---|
| Risk-stratified Sequential Treatment of Post-transplant Lymphoproliferative Disease (PTLD) With Rituximab SC and Immunochemotherapy (NCT02042391) | Diako Ev. Diakonie-Krankenhaus gemeinnützige GmbH | 2015-02-03 |
Track Diako Ev. Diakonie-Krankenhaus gemeinnützige GmbH automatically
Every clearance here is in the API, with alerts when new ones post.